Finally, a consensus statement on sickle cell disease manifestations: A critical step in improving the medical care and research agenda for individuals with sickle cell disease

American Journal of Hematology

Volumn 85, Issue 1, 2010, Pages 1-3

  DeBaun, Michael R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CHEST SYNDROME; ACUTE VASOOCCLUSIVE PAIN; BRONCHIOLITIS; CLINICAL FEATURE; CONSENSUS; FAMILY; FEVER; GENE REPLICATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETICS; GENOMICS; HEALTH CARE PERSONNEL; HEMATOLOGY; HOSPITALIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL CARE; MEDICAL RESEARCH; NOTE; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; PROTEOMICS; SICKLE CELL ANEMIA; WHEEZING; CONSENSUS DEVELOPMENT; HUMAN;

ANEMIA, SICKLE CELL; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES;

EID: 74049103034     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21583     Document Type: Note

References (15)

1. Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 2009, Sept. 24 [Epub ahead of print].
2. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84:643-649.
3. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: Clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997;89:1787-1792.
4. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-1865.
5. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-69.
6. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 1999;94:1555-1560.
7. Davies SC, Luce PJ, Win AA, et al. Acute chest syndrome in sickle-cell disease. Lancet 1984;1:36-38.
8. Field JJ, Knight-Perry JE, DeBaun MR. Acute pain in children and adults with sickle cell disease: Management in the absence of evidence-based guidelines. Curr Opin Hematol 2009;16:173-178.
9. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
10. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000;342:83-89.
11. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322.
12. Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anemia - Clinical utility of myelosuppressive "switching" agent. Medicine 1996;75: 300-326.
13. Ballas SK, Larner J, Smith ED, et al. Rheologic predictors of the severity of the painful sickle cell crisis. Blood 1988;72:1216-1223.
14. Morris CR, Kuypers FA, Larkin S, et al. Arginine therapy: A novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol 2000;111: 498-500.
15. Smith WR, Penberthy LT, Bovberg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann of Intern Med 2008;148:94-101.